These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 19766126)
1. The effect of intrinsic stochasticity on transmitted HIV drug resistance patterns. Marks AJ; Pillay D; McLean AR J Theor Biol; 2010 Jan; 262(1):1-13. PubMed ID: 19766126 [TBL] [Abstract][Full Text] [Related]
2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
3. Epidemiology of antiretroviral drug resistance in drug-naïve persons. Geretti AM Curr Opin Infect Dis; 2007 Feb; 20(1):22-32. PubMed ID: 17197878 [TBL] [Abstract][Full Text] [Related]
4. Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection. Booth CL; Geretti AM J Antimicrob Chemother; 2007 Jun; 59(6):1047-56. PubMed ID: 17449483 [TBL] [Abstract][Full Text] [Related]
5. The emergence and epidemiology of resistance in the nucleoside-experienced HIV-infected population. Pillay D Antivir Ther; 2001; 6 Suppl 3():15-24. PubMed ID: 11678470 [TBL] [Abstract][Full Text] [Related]
6. Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey. Yerly S; von Wyl V; Ledergerber B; Böni J; Schüpbach J; Bürgisser P; Klimkait T; Rickenbach M; Kaiser L; Günthard HF; Perrin L; AIDS; 2007 Oct; 21(16):2223-9. PubMed ID: 18090050 [TBL] [Abstract][Full Text] [Related]
7. 2004: which HIV-1 drug resistance mutations are common in clinical practice? Cheung PK; Wynhoven B; Harrigan PR AIDS Rev; 2004; 6(2):107-16. PubMed ID: 15332433 [TBL] [Abstract][Full Text] [Related]
8. Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population. Leigh Brown AJ; Frost SD; Mathews WC; Dawson K; Hellmann NS; Daar ES; Richman DD; Little SJ J Infect Dis; 2003 Feb; 187(4):683-6. PubMed ID: 12599087 [TBL] [Abstract][Full Text] [Related]
9. Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world. Frentz D; Boucher CA; van de Vijver DA AIDS Rev; 2012; 14(1):17-27. PubMed ID: 22297501 [TBL] [Abstract][Full Text] [Related]
10. Transmitted drug-resistant HIV-1 in primary HIV-1 infection; incidence, evolution and impact on response to antiretroviral therapy. Fox J; Dustan S; McClure M; Weber J; Fidler S HIV Med; 2006 Oct; 7(7):477-83. PubMed ID: 16925735 [TBL] [Abstract][Full Text] [Related]
11. Declining prevalence of HIV-1 drug resistance in treatment-failing patients: a clinical cohort study. Di Giambenedetto S; Bracciale L; Colafigli M; Cattani P; Pinnetti C; Bacarelli A; Prosperi M; Fadda G; Cauda R; De Luca A Antivir Ther; 2007; 12(5):835-9. PubMed ID: 17713168 [TBL] [Abstract][Full Text] [Related]
12. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients. Rodes B; García F; Gutierrez C; Martinez-Picado J; Aguilera A; Saumoy M; Vallejo A; Domingo P; Dalmau D; Ribas MA; Blanco JL; Pedreira J; Perez-Elias MJ; Leal M; de Mendoza C; Soriano V; J Med Virol; 2005 Sep; 77(1):23-8. PubMed ID: 16032728 [TBL] [Abstract][Full Text] [Related]
13. Transmission of drug-resistant HIV-1 in Europe remains limited to single classes. SPREAD programme AIDS; 2008 Mar; 22(5):625-35. PubMed ID: 18317004 [TBL] [Abstract][Full Text] [Related]
14. Current patterns in the epidemiology of primary HIV drug resistance in North America and Europe. Pillay D Antivir Ther; 2004 Oct; 9(5):695-702. PubMed ID: 15535406 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy. Novak RM; Chen L; MacArthur RD; Baxter JD; Huppler Hullsiek K; Peng G; Xiang Y; Henely C; Schmetter B; Uy J; van den Berg-Wolf M; Kozal M; Clin Infect Dis; 2005 Feb; 40(3):468-74. PubMed ID: 15668873 [TBL] [Abstract][Full Text] [Related]
16. HIV drug resistance transmission threshold survey in Bangkok, Thailand. Sirivichayakul S; Phanuphak P; Pankam T; O-Charoen R; Sutherland D; Ruxrungtham K Antivir Ther; 2008; 13 Suppl 2():109-13. PubMed ID: 18575199 [TBL] [Abstract][Full Text] [Related]
17. Threshold survey evaluating transmitted HIV drug resistance among public antenatal clinic clients in Addis Ababa, Ethiopia. Abegaz WE; Grossman Z; Wolday D; Ram D; Kaplan J; Sibide K; Wuhib T; Ismael S; Nkengasong J; Mekonen T; Berhanu H; Messele T; Lulseged S; Maayan S; Mengistu Y Antivir Ther; 2008; 13 Suppl 2():89-94. PubMed ID: 18575196 [TBL] [Abstract][Full Text] [Related]
18. Worldwide transmission of drug-resistant HIV. Wensing AM; Boucher CA AIDS Rev; 2003; 5(3):140-55. PubMed ID: 14598563 [TBL] [Abstract][Full Text] [Related]
19. The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa. Hamers RL; Derdelinckx I; van Vugt M; Stevens W; Rinke de Wit TF; Schuurman R; Antivir Ther; 2008; 13(5):625-39. PubMed ID: 18771046 [TBL] [Abstract][Full Text] [Related]
20. Infrequent transmission of HIV-1 drug-resistant variants. Yerly S; Jost S; Telenti A; Flepp M; Kaiser L; Chave JP; Vernazza P; Battegay M; Furrer H; Chanzy B; Burgisser P; Rickenbach M; Gebhardt M; Bernard MC; Perneger T; Hirschel B; Perrin L; Antivir Ther; 2004 Jun; 9(3):375-84. PubMed ID: 15259900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]